AEON Biopharma AEON
NYSE AEON
$0.24 +0.01 (+2.21%)
As of: Oct 20, 2026 · 1:34 PM EDT

AEON Biopharma (AEON) Capital Expenditures (2022 - 2025)

Updated

AEON Biopharma (AEON) reported Capital Expenditures of $4,000 for FY2025.

Analysis

AEON Biopharma (AEON) Capital Expenditures (2022 - 2025) Analysis & Trends

  • Capital Expenditures has a three-year compound annual growth rate of -76.4% (FY2022 to FY2025).
  • The FY2025 figure ranks as the highest annual Capital Expenditures since FY2022.
  • According to Business Quant data, Capital Expenditures came in at $306,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,155.65 Bn 1,124.24 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 623.71 Bn 542.24 Bn 17.26 Bn 1.32 Bn
3 AbbVie 512.92 Bn 486.03 Bn 12.70 Bn 322.00 Mn
4 Merck 365.46 Bn 319.84 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 297.38 Bn 261.37 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.52 Bn 235.20 Bn 12.86 Bn 1.86 Bn
7 Amgen 235.15 Bn 190.55 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 193.26 Bn 167.45 Bn 6.22 Bn 140.00 Mn
9 Pfizer 171.63 Bn 118.27 Bn 10.94 Bn 533.00 Mn
10 AEON Biopharma 11.93 Mn -8.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 4,000.00
Dec 31, 2022 9,000.00
API Access

AEON Biopharma Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AEON&period=max&api_key=YOUR_API_KEY